You are here

Eu Yan Sang seeking alternative prescription with SGX exit?

Late trading suspension sets market abuzz with talk of delisting offer; stock jumps 10 per cent before suspension

BT_20160512_MLEU12_2275272.jpg
Eu Yan Sang group CEO Richard Eu. The potential privatisation attempt by the firm is believed to be handled by Credit Suisse.

Singapore

THE exodus of consumer stocks from the Singapore bourse looks set to continue.

Trading in the shares of traditional Chinese medicine (TCM) retailer Eu Yan Sang International remained halted on Wednesday amid growing market talk that a move has been made to take it private